MedCity News December 27, 2024
Marissa Plescia

Fidelity Management & Research Company and Dexcom participated in ŌURA’s $200 million Series D round.

ŌURA, a wearable device company, has secured $200 million in Series D funding to expand its product offerings, the company announced last week.

ŌURA, which was founded in Finland in 2013, offers a wearable smart ring called the Oura Ring, as well as an accompanying app. The ring provides personalized insights and guidance on sleep, activity, readiness, stress, resilience, women’s health and heart health. People can purchase an Oura Ring starting at $249.

Fidelity Management & Research Company and Dexcom, a continuous glucose monitoring company, participated in ŌURA’s $200 million Series D round. To date, ŌURA has raised more than $550 million, and its Series...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Investments, Technology, Trends, Wearables
The future of cardiac monitoring: AI-powered wearables in practice
Continuous Glucose Monitors Predict Type 1 Diabetes Complications
AI in Smartwatches Enhances Health Event Prediction
Utilizing AI-Enabled Remote Wearables for Lifesaving Care
Where Does Diabetes Technology Stand In 2025?

Share This Article